The latter has very important therapeutic consequences for treatment of autoimmune diseases, in particular, multiple sclerosis, mediated by myelin reactive TEM, by specific and non-toxic Kv1.3 blockers (reviewed by Panyi, 2005). The gene discussed is KCNA3; the disease is autoimmune disease.